Authors: Martha Powell, Future Science Group
A capsule has been developed that could deliver a week’s worth of HIV drugs in a single dose, this advance could make it easier for patients to adhere to medication schedules, according to new research.
Medication non-adherence is a major challenge in the fight against HIV, with studies demonstrating that only about 30% of patients stick to their dosage plans. The novel capsule, designed by Brigham and Women’s Hospital, Massachusetts Institute of Technology (both MA, USA) and collaborators, hopes to provide a once-weekly pill that could have uses in treating and preventing HIV.
To view restricted content, please:
